PATH vs PTN · P/E 19, rev $1.61B vs P/E 111, $21.8M cap
Uipath Inc (PATH) versus Palatin Technologies, Inc. Common Stock (PTN) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Palatin Technologies, Inc. Common Stock (PTN) is a biotechnology company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported PTN revenue for 2025-06-30 was $0. Net income was -$17.3M. Revenue was down 100.0% from 2024-06-30 to 2025-06-30. PTN currently screens at market cap $21.8M and trailing P/E 111.4.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. PTN currently screens at market cap $21.8M and trailing P/E 111.4.
Not investment advice. Open the PATH and PTN stock pages for the full models.
Not investment advice.